The present disclosure relates to surgical buttresses and equipment for their manufacture, and more particularly, to a spinneret configured to make a nonwoven fabric surgical implant or buttress created from a melt blown process.
Surgical stapling instruments that are used to sequentially or simultaneously apply one or more rows of fasteners to join segments of body tissues are well known in the art. Such devices generally include a pair of jaws to clamp therebetween the body tissues to be joined. Typically, one of the jaw members includes a staple cartridge which accommodates a plurality of staples while the other jaw member has an anvil that defines a surface for forming the staple legs as the staples are driven from the staple cartridge. When stapling relatively thin or fragile tissues, it is often necessary to reinforce the staple line against the tissue to prevent tears in the tissue or pulling of the staples through the tissue. One method of preventing tears or pull through involves the placement of a biocompatible fabric reinforcing material, or a “buttress,” between the staple and the underlying tissue.
A common method for making a buttress is to extrude a biocompatible material through a spinneret having a unimodal distribution of hole diameters to form fibers, collect the fibers to create a fiber mat and then cut the nonwoven fiber mat into a predetermined shape. However, using a spinneret with a unimodal distribution of hole diameters produces a buttress having a certain flexibility and strength.
It is a desire of the present application to provide a spinneret, system and method for making a nonwoven fiber mat that results in a buttress having improved flexibility and strength characteristics.
Specifically, this disclosure presents a spinneret design that includes at least a distribution of hole diameters to create fibers with a more heterogeneous shear history and die swell. All of these advantages confer unique fabric properties not attainable with unimodal spinneret hole diameters such as differentiated load deflection behavior, flexural stiffness, polymer fiber alignment, fiber crystallinity and subsequent strength retention during in vivo degradation.
In accordance with aspects of the present disclosure, a multi-modal spinneret is provided, including a body defining a longitudinal axis, wherein the body includes a first side surface and a second side surface, and a top surface and a bottom surface; and at least two holes disposed along the longitudinal axis of the spinneret, each of the at least two holes having a hole diameter, wherein at least one hole has a first diameter and least one hole has a second diameter different than the first diameter.
The spinneret can include additional holes, and wherein each of the additional holes has a hole diameter equivalent to either the first or second diameter. The additional holes of the spinneret may be disposed along the longitudinal axis of the spinneret in a pattern of alternating first and second diameters or randomly disposed along the longitudinal axis of the spinneret. The number of holes having a first diameter and the number of holes having a second diameter may be equal.
In aspects, each of the additional holes has a center and an edge, the additional holes may be disposed along the longitudinal axis of the spinneret such that the centers of the additional holes are equidistant or the distance between each edge of each of the additional holes are equidistant.
In aspects, the at least two holes of the spinneret have a hole depth, and wherein each of the at least two holes has a ratio that is defined by the hole depth divided by the hole diameter. Each of the ratios of the at least two holes may be equal or unequal.
In accordance with another aspect of the present disclosure, a method of making a nonwoven fiber mat is disclosed and comprises providing a material, an extruder and a spinneret, wherein the spinneret defines at least one hole having one diameter and at least one hole having a second diameter different than the first diameter; coupling the spinneret to the extruder; feeding the material into the extruder; melting the material in the extruder; extruding the melted material through the spinneret forming a plurality of fibers; and collecting the plurality of fibers onto a conveyer surface to form a nonwoven fiber mat, wherein the nonwoven fiber mat includes at least one fiber having a first diameter and at least one fiber having a second diameter.
In certain embodiments, the material is a polymer selected from the group consisting of lactide homopolymer, glycolide homopolymer, polydioxanone homopolymer, glycolide trimethylene carbonate copolymer, glycolide lactide copolymer, glycolide dioxanone trimethylene carbonate copolymer, and glycolide caprolactone trimethylene carbonate lactide copolymer.
In certain embodiments, the material is a bioabsorbable polymeric material. The melting temperature of the polymer may be between about 180 and about 270 degrees Celsius. In other embodiments, the melting temperature of the polymer is between about 80 degrees Celsius and about 190 degrees Celsius.
The method may also include blowing hot air on the plurality of fibers as they exit the spinneret and before they are collected on the conveyer surface. The hot air may have a temperature greater than or equal to the melting temperature of the plurality of fibers. The hot air may have a temperature of between about 225 and about 290 degrees Celsius. The hot air may have a temperature of about 240 degrees Celsius.
In certain embodiments, the method includes plasma treating at least a portion of a surface of the non-woven fiber mat with an ionizable gas species or combination of ionizable gas species configured to chemically modify or functionalize the surface of the non-woven fiber mat. The ionizable gas species is selected from the group consisting of air, water vapor, oxygen, nitrogen, argon, and combinations thereof.
In certain embodiments, the method includes applying heat and pressure to the non-woven fiber mat before plasma treating the non-woven fiber mat.
In certain embodiments, the non-woven material is cut into a shape corresponding to the shape of the tissue contacting surfaces of a linear surgical stapler. In other embodiments, the non-woven material is cut into a shape corresponding to the shape of the tissue contacting surfaces of a circular surgical stapler.
In accordance with another aspect of the present disclosure, a system for making a surgical buttress for surgical staplers is disclosed and comprises an extruder configured to receive and melt a material; a spinneret coupled to the extruder and configured to form a plurality of fibers, wherein the spinneret defines at least two holes of different sizes; and a conveyer surface configured to receive the plurality of fibers extruded from the spinneret. The extruder may reach a temperature between about 180 and about 270 degrees Celsius or temperatures between about 80 degrees Celsius and about 190 degrees Celsius. The system may include a blower and/or compressed air, wherein the blower and/or compressed air blows hot air on the plurality of fibers as they exit the spinneret.
In certain embodiments, the hot air from the blower and/or compressed air may have a temperature greater than or equal to the melting temperature of the plurality of fibers. The hot air may have a temperature approximately between 225 and 290 degrees Celsius.
In certain embodiments, the system may include a plasma treatment apparatus, wherein the plasma treatment apparatus treats at least a portion of a surface of the non-woven fiber mat with an ionizable gas species or combination of ionizable gas species configured to chemically modify or functionalize the surface of the non-woven fiber mat. The ionizable gas species is selected from the group consisting of air, water vapor, oxygen, nitrogen, argon, and combinations thereof.
In certain embodiments, the system may include a cutting apparatus to cut the nonwoven fiber mat into a buttress. The non-woven fiber mat is cut into a shape corresponding to the shape of the tissue contacting surfaces a linear surgical stapler or into a shape corresponding to the shape of the tissue contacting surfaces a circular surgical stapler.
The foregoing objects and advantages of the disclosure will become more apparent from the reading of the following description in connection with the accompanying drawings, in which:
The present disclosure is directed to a spinneret design, system and method of using a melt blown process to make a nonwoven fiber mat having a distribution of fiber diameters.
For the purposes of discussion, the nonwoven fiber mat will be discussed in terms of a surgical buttress. However, those skilled in the art will appreciate the presently disclosed nonwoven fiber mat may be any surgical implant, such as meshes, scaffolds, grafts (e.g., fabrics and/or tubes), rings, sutures, patches, slings, pledgets, growth matrices, drug delivery devices, wound plugs, and, in general, soft tissue repair devices and surgical prostheses. In other embodiments, a suitable nonwoven fiber mat may be cut as topically applied medical products, such as wound dressings, coverings, gauzes, and the like, that can be used in medical/surgical procedures.
Referring now to the figures, wherein like components are designated by like reference numerals throughout the several views,
With reference to
Still referring to
Turning to
Shown in
Referring back to
In embodiments, material 210 may be a lactomer copolymer of glycolide and lactide derived from glycolic and lactic acids. In embodiments, the porous nonwoven fiber mat may be fabricated from polyglyconate, a copolymer of glycolic acid and trimethylene carbonate.
In other embodiments, material 210 may be a synthetic polyester composed of glycolide, dioxanone, and trimethylene carbonate. The polymer may include from about from about 50% to about 70% by weight glycolide, in embodiments, from about 55% to about 65% by weight glycolide, and in some embodiments, about 60% by weight glycolide; from about 4% to about 24% by weight dioxanone, in embodiments, from about 9% to about 19% by weight dioxanone, and in some embodiments, about 14% by weight dioxanone; and from about 16% to about 36% by weight trimethyl carbonate, in embodiments, from about 21% to about 31% by weight trimethyl carbonate, and in some embodiments, about 26% by weight trimethyl carbonate.
In yet other embodiments, material 210 may be a copolymer of glycolide and trimethylene carbonate. The polymer may include from about 55% to about 75% by weight glycolide, in embodiments, about 60% to about 70% by weight glycolide, and in some embodiments, about 65% by weight glycolide, and from about 25% to about 45% by weight trimethylene carbonate, in embodiments, from about 30% to about 40% by weight trimethylene carbonate, and in some embodiments, about 35% by weight trimethylene carbonate.
Extruder 200 is configured to heat material 210 until it becomes a melted material 220, and then forces melted material 220 into spinneret 100 and through the array of holes therein. In some embodiments, the temperature of spinneret 100 is between about 200 degrees Celsius, and about 275 degrees Celsius in some embodiments, from between about 235 degrees Celsius and about 255 degrees Celsius. In some embodiments, the pressure, at spinneret 100, acting on melted material 220, is between about 10 bar and about 80 bar. In some embodiments, the pressure can be 125 bar.
Spinneret 100 forms melted material 220 into fibers 400 having differing fiber diameters. Blower and/or compressed air 500 blows hot air onto fibers 400 exiting spinneret 100 to force fibers 400 onto a conveyor surface 600. In some embodiments, the hot air has a temperature of between about 225 degrees Celsius and about 325 degrees Celsius, and in other embodiments hot air has a temperature from about 265 degrees Celsius and about 295 degrees Celsius. The speed of conveyor surface 600 is between about 1 meter per minute and about 10 meters per minute. Fibers 400 randomly land on conveyor surface and build up to several layers in thickness. Suction 610 is applied through conveyor surface 600 to help compact fibers 400 against each other to form a nonwoven fiber mat 410 as fibers 400 cool.
It is contemplated that fibers 400 can be generated at lower temperatures. In certain embodiments, fibers 400 are formed from a material 210 having a lower melting temperature. For example, a copolymer of glycolide, caprolactone, trimethylene carbonate and lactide could be melt extruded at between about 140 degrees Celsius and about 185 degrees Celsius. Thus, the nonwoven fiber mat 410 may be formed from fibers 400 that are melt extruded from polymers having a melting temperature of between about 80 degrees Celsius and about 190 degrees Celsius.
The diameter of the individual fibers 400 may be from about 5 μm to about 100 μm in embodiments, from about 10 μm to about 40 μm in some embodiments, and from about 15 μm to about 35 μm in some embodiments, and in some further embodiments, from about 18 μm to about 33 μm. The nonwoven fiber mat 410 thickness may be from about 100 μm to about 400 μm in embodiments, and from about 100 μm to about 300 μm in some embodiments, and from about 200 μm to about 250 microns in some embodiments, and in some further embodiments about 230 μm. The nonwoven fiber mat 410 weight may be from about 75 g/m2 to about 100 g/m2, in embodiments, from about 80 g/m2 to about 95 g/m2, and in some embodiments, about 87 g/m2. It should be understood that different mat thicknesses, weights, and porosities may be selected by varying manufacturing conditions. In certain embodiments, the fabric can be between 35 to 80 g/m2.
In accordance with the present disclosure, the nonwoven fiber mat 410 may be chemically modified to render at least a portion of a surface of nonwoven fiber mat 410 hydrophilic. For example, in embodiments, the nonwoven fiber mat 410 is carried on conveyer surface 600 and delivered to a plasma apparatus 700 where a plasma treatment is used. The plasma may be formed of a single gas species such as oxygen, carbon dioxide, ammonia, nitrogen, or argon. The use of oxygen, for example, will result in surface activation of an oxygenate type, such as the formation of —OH, —CHO, and/or —COOH groups. It is envisioned that other gases, mixtures of gases, vapours of volatile organic molecules such as alcohols, water, or open air plasma may also be utilized. For example, ozone may be used in place of oxygen. In other examples, the plasma gas may be produced using an oxygen-containing molecule, a nitrogen-containing molecule, or mixtures thereof. In some embodiments, plasma gases may be used serially.
Once fiber mat 410 is plasma treated, nonwoven fiber mat 410 is carried on conveyor surface 600 and delivered to a cutting apparatus 800. Cutting apparatus 800 cuts nonwoven fiber mat 410 into a surgical buttress having a profile corresponding to a linear or circular stapling instrument.
An illustrative plasma apparatus is shown in
Preferably, the nonwoven fiber mat 410 may travel through the plasma field between reels in a continuous reel to reel system requiring no support rack. Alternatively, the nonwoven fiber mat 410 is mounted within the chamber 721 on the rack 722, positioned between electrode plates 724 and 726. Alternatively, the rack 722 may be movable so that nonwoven fiber mat 410 may be pulled through the chamber 721. The gas inlet system 732 is operated to permit reacting gas monomer from plasma gas source 730 to flow into the chamber 721 through the supply line 734 before generating a plasma.
The plasma is created by applying the output of the radio frequency generator 723 to the electrode plate 724. The power supplied by the generator 723 is at the minimum required to sustain the plasma, as higher powered plasma will only degrade the surface of nonwoven fiber mat 410. The reaction between the plasma and nonwoven fiber mat 410 is allowed to proceed for a period of time determined by the desired thickness and surface energy on nonwoven fiber mat 410 and the concentration of gas monomers in the reacting vapor. The pressure within the chamber 721 is measured by a capacitance manometer 746 to maintain appropriate pressure throughout the reaction period.
Following the reaction period, the flow of gas from the plasma gas source 730 is terminated, the power from the generator 723 sustaining the plasma is turned off, and valve 738 is opened to permit gas to flow into the chamber 721 from purge gas source 742 to purge nonwoven fiber mat 410 surface of highly reactive radicals which could cause premature contamination of nonwoven fiber mat's 410 surface. Valve 838 is then closed, the chamber 721 is opened so that chamber 721 is returned to atmospheric pressure, and the plasma treated nonwoven fiber mat 410 is removed.
The plasma treated nonwoven fiber mat 410 may then be sterilized by any means within the purview of those skilled in the art including, but not limited to, ethylene oxide, electron beam, gamma irradiation, autoclaving, plasma sterilization, and the like.
It should be understood that the conditions under which treatment occurs may be dependent upon a number of factors, such as the type, size, thickness, and porosity of material being treated, the type and concentration of gas species being utilized and the flow rate thereof, the plasma technology system being utilized, and plasma treatment conditions such as voltage, pressure, temperature, duration, and the like.
For example, the plasma may include from about 1% to about 100% by weight of oxygen, nitrogen, or argon, in embodiments, from about 15% to about 90% by weight of oxygen, nitrogen, or argon, and in some embodiments, from about 25% to about 75% by weight oxygen, nitrogen, or argon. The gas may have a mass flow rate of from about 10 sccm to about 200 sccm, in embodiments, from about 25 sccm to about 150 sccm, and in some embodiments, about 50 sccm to about 100 sccm. The plasma generating electrodes may operate at a power of about 25 watts to about 1000 watts, in embodiments, from about 50 watts to about 750 watts, and in some embodiments, about 100 watts to about 500 watts. The treatment pressure may be about 25 mtorr to about 500 mtorr, in embodiments, from about 50 mtorr to about 400 mtorr, and in some embodiments, from about 100 mtorr to about 250 mtorr. The treatment may occur at a temperature of less than 100° C., and, in embodiments, at ambient temperature. The length of exposure may range from about 10 seconds to about 120 minutes, in embodiments, from about 30 seconds to about 60 minutes, and in some embodiments, from about 2 minutes to about 30 minutes. It will be appreciated by those skilled in the art that the treatment conditions may be outside the ranges set forth as discussed above.
In embodiments, the nonwoven fiber mat 410 treated in accordance with the present disclosure may also be subjected to a plasma polymerization process to form a polymer coating on at least a portion of the surface of nonwoven fiber mat 410. Such methods are disclosed, for example, in U.S. Pat. No. 7,294,357 and U.S. Patent Application Publication No. 2013/0123816 the entire contents of which are incorporated herein by reference.
The monomers used to form the polymer coating may be polymerized directly on nonwoven fiber mat's 410 surface using plasma-state polymerization techniques generally known to those skilled in the art. In brief, the monomers are polymerized onto the surface of nonwoven fiber mat 410 by activating the monomer in a plasma state. The plasma state generates highly reactive species, which form a highly cross-linked and highly-branched ultra-thin polymer coating, which is deposited on the surface of nonwoven fiber mat 410 during plasma polymerization.
In embodiments, a suitable organic monomer or a mixture of monomers having polymerizable unsaturated groups is introduced into the chamber where it is fragmented and/or activated forming further excited species in addition to the activated plasma gases. The excited species and fragments of the monomer recombine upon contact with the surface of nonwoven fiber mat 410 to form a largely undefined structure which contains a complex variety of different groups and chemical bonds and forms a highly cross-linked polymer coating. If oxygen, nitrogen, argon, or molecules possessing these elements are present, either within the plasma reactor during the polymer coating process or on exposure of the polymer coated nonwoven fiber mat 410 to oxygen or air subsequent to the plasma process, the polymeric deposit will include a variety of polar groups.
In embodiments, plasma polymerization may utilize solvents such as diglyme and tetraglyme, to produced PEG-like surfaces. In other embodiments, plasma polymerization may utilize fluorochemicals such as aliphatic fluorine-containing gases, to produced fluorinated polymer surfaces.
The amount and relative position of polymer deposition on the nonwoven fiber mat 410 is influenced by at least three geometric factors: (1) location of the electrode plates and distribution of charge; (2) monomer flow; and (3) nonwoven fiber mat 410 position within the chamber. In practice, an electric discharge from the RF generator may be applied to the electrode plates within the chamber and the selected monomers may be introduced into the chamber and energized into a plasma, saturating the space between the electrode plates with an abundance of energetic free radicals and lesser amounts of ions and free electrons produced by the monomers. As nonwoven fiber mat 410 is passed through, or positioned between, the electrode plates, the surface of nonwoven fiber mat 410 is bombarded with free radicals, resulting in the formation of the polymer coating.
In embodiments, siloxane monomers with hydrophilic end groups may be used in the plasma polymerization process to produce polymer coatings on the surface of nonwoven fiber mat 410. In some embodiments, aliphatic hydrocyclosiloxane monomers, alone or mixed with co-monomers, may be utilized to provide polymer coatings having a homogenous or mixed property coating. For example, by introducing reactive functionalizing monomers, organo-based monomers, or fluorocarbon monomers together with the aliphatic hydrocyclosiloxane monomers in the plasma polymerization system, physical pore size and chemical affinity of the plasma copolymerized aliphatic hydrocyclosiloxane coating with selective monomers can be controlled. This allows the use of the copolymerized plasma polymer coating for applications which require the coating to differentiate between certain types of gases, ions, and molecules and it also may be utilized to introduce functional groups to the polymer coating which, in turn, can help link hydrophilic molecules to the polymer coating.
Referring now to
Initially, as indicated in step 810, the extruder 200 is supplied with an appropriate amount of a material 210. Next, extruder 200 is activated. Once activated, as indicated in step 820, extruder 200 heats material 210 until it changes into melted material 220. Extruder 200 then proceeds to force melted material 220 through the array of holes 110 (See
The method may also include plasma treating non-woven fiber mat 410. Indicated in step 860, non-woven fiber mat 410 is delivered to a plasma treatment apparatus 700. Delivery may be by conveyor surface 600 or manually. In step 870, plasma treatment apparatus 700 is activated thereby surface treating non-woven fiber mat 410. A detailed discussion of the operation of plasma treatment apparatus 700 is discussed with reference to
While several embodiments of the disclosure have been shown in the drawings, it is not intended that the disclosure be limited thereto, as it is intended that the disclosure be as broad in scope as the art will allow and that the specification be read likewise. For example, a bimodal spinneret has been disclosed, but multiple different diameter holes can be used in other embodiments. In any of the embodiments disclosed herein, the holes can be arranged in a pattern or randomly. The spacing may be equidistant or otherwise. In certain embodiments, techniques for injecting cold air to the molten polymer can be used and/or techniques for removing process heat from the system during fiber mat deposition can be used. In any of the embodiments disclosed herein the material may be annealed. In any of the embodiments, the material may be formed or cut into sheets, threads, or three dimensional shapes can be made. In certain embodiments, a dye may be used to achieve a characteristic color or to make the material radio-opaque. In any of the embodiments, a step of applying pressure or compressing the material may be used to condense the material, improve thickness control or for some other reason. Therefore, the above description should not be construed as limited, but merely as exemplifications of particular embodiments. Those skilled in the art will envision other modifications within the scope and spirit of the claims appended hereto.
Number | Name | Date | Kind |
---|---|---|---|
3054406 | Usher | Sep 1962 | A |
3079606 | Bobrov et al. | Mar 1963 | A |
3124136 | Usher | Mar 1964 | A |
3364200 | Ashton et al. | Jan 1968 | A |
3490675 | Green et al. | Jan 1970 | A |
3499591 | Green | Mar 1970 | A |
3939068 | Wendt et al. | Feb 1976 | A |
3948666 | Kitanishi et al. | Apr 1976 | A |
4064062 | Yurko | Dec 1977 | A |
4166800 | Fong | Sep 1979 | A |
4282236 | Broom | Aug 1981 | A |
4347847 | Usher | Sep 1982 | A |
4354628 | Green | Oct 1982 | A |
4416698 | McCorsley, III | Nov 1983 | A |
4429695 | Green | Feb 1984 | A |
4452245 | Usher | Jun 1984 | A |
4605730 | Shalaby et al. | Aug 1986 | A |
4626253 | Broadnax, Jr. | Dec 1986 | A |
4655221 | Devereux | Apr 1987 | A |
4834090 | Moore | May 1989 | A |
4838884 | Duncan et al. | Jun 1989 | A |
4927640 | Dahlinder et al. | May 1990 | A |
4930674 | Barak | Jun 1990 | A |
5002551 | Linsky et al. | Mar 1991 | A |
5014899 | Presty et al. | May 1991 | A |
5040715 | Green et al. | Aug 1991 | A |
5057334 | Vail | Oct 1991 | A |
5065929 | Schulze et al. | Nov 1991 | A |
5162430 | Rhee et al. | Nov 1992 | A |
5205459 | Brinkerhoff et al. | Apr 1993 | A |
5263629 | Trumbull et al. | Nov 1993 | A |
5266255 | Gibbon | Nov 1993 | A |
5307976 | Olson et al. | May 1994 | A |
5312023 | Green et al. | May 1994 | A |
5314471 | Brauker et al. | May 1994 | A |
5318221 | Green et al. | Jun 1994 | A |
5324775 | Rhee et al. | Jun 1994 | A |
5326013 | Green et al. | Jul 1994 | A |
5332142 | Robinson et al. | Jul 1994 | A |
5344454 | Clarke et al. | Sep 1994 | A |
5392979 | Green et al. | Feb 1995 | A |
5397324 | Carroll et al. | Mar 1995 | A |
5410016 | Hubbell et al. | Apr 1995 | A |
5425745 | Green et al. | Jun 1995 | A |
5441193 | Gravener | Aug 1995 | A |
5441507 | Wilk | Aug 1995 | A |
5443198 | Viola et al. | Aug 1995 | A |
5468253 | Bezwada et al. | Nov 1995 | A |
5484913 | Stilwell et al. | Jan 1996 | A |
5503638 | Cooper et al. | Apr 1996 | A |
5514379 | Weissleder et al. | May 1996 | A |
5542594 | McKean et al. | Aug 1996 | A |
5543441 | Rhee et al. | Aug 1996 | A |
5549628 | Cooper et al. | Aug 1996 | A |
5550187 | Rhee et al. | Aug 1996 | A |
5575803 | Cooper et al. | Nov 1996 | A |
5653756 | Clarke et al. | Aug 1997 | A |
5683809 | Freeman et al. | Nov 1997 | A |
5690675 | Sawyer et al. | Nov 1997 | A |
5702409 | Rayburn et al. | Dec 1997 | A |
5752965 | Francis et al. | May 1998 | A |
5752974 | Rhee et al. | May 1998 | A |
5762256 | Mastri et al. | Jun 1998 | A |
5766188 | Igaki | Jun 1998 | A |
5769892 | Kingwell | Jun 1998 | A |
5782396 | Mastri et al. | Jul 1998 | A |
5799857 | Robertson et al. | Sep 1998 | A |
5810855 | Rayburn et al. | Sep 1998 | A |
5814057 | Oi et al. | Sep 1998 | A |
5819350 | Wang | Oct 1998 | A |
5833695 | Yoon | Nov 1998 | A |
5843096 | Igaki et al. | Dec 1998 | A |
5874500 | Rhee et al. | Feb 1999 | A |
5895412 | Tucker | Apr 1999 | A |
5895415 | Chow et al. | Apr 1999 | A |
5902312 | Frater et al. | May 1999 | A |
5908427 | McKean et al. | Jun 1999 | A |
5915616 | Viola et al. | Jun 1999 | A |
5931847 | Bittner et al. | Aug 1999 | A |
5964774 | McKean et al. | Oct 1999 | A |
5997895 | Narotam et al. | Dec 1999 | A |
6019791 | Wood | Feb 2000 | A |
6030392 | Dakov | Feb 2000 | A |
6032849 | Mastri et al. | Mar 2000 | A |
6045560 | McKean et al. | Apr 2000 | A |
6063097 | Oi et al. | May 2000 | A |
6080169 | Turtel | Jun 2000 | A |
6093557 | Pui et al. | Jul 2000 | A |
6099551 | Gabbay | Aug 2000 | A |
6149667 | Hovland et al. | Nov 2000 | A |
6152943 | Sawhney | Nov 2000 | A |
6155265 | Hammerslag | Dec 2000 | A |
6156677 | Brown Reed et al. | Dec 2000 | A |
6165201 | Sawhney et al. | Dec 2000 | A |
6179862 | Sawhney | Jan 2001 | B1 |
6210439 | Firmin et al. | Apr 2001 | B1 |
6214020 | Mulhauser et al. | Apr 2001 | B1 |
6241139 | Milliman et al. | Jun 2001 | B1 |
6258107 | Balazs et al. | Jul 2001 | B1 |
6267772 | Mulhauser et al. | Jul 2001 | B1 |
6273897 | Dalessandro et al. | Aug 2001 | B1 |
6280453 | Kugel et al. | Aug 2001 | B1 |
6299631 | Shalaby | Oct 2001 | B1 |
6309569 | Farrar et al. | Oct 2001 | B1 |
6312457 | DiMatteo et al. | Nov 2001 | B1 |
6312474 | Francis et al. | Nov 2001 | B1 |
6319865 | Mikami | Nov 2001 | B1 |
6325810 | Hamilton et al. | Dec 2001 | B1 |
6399362 | Pui et al. | Jun 2002 | B1 |
6436030 | Rehil | Aug 2002 | B2 |
6454780 | Wallace | Sep 2002 | B1 |
6461368 | Fogarty et al. | Oct 2002 | B2 |
6500777 | Wiseman et al. | Dec 2002 | B1 |
6503257 | Grant et al. | Jan 2003 | B2 |
6514283 | DiMatteo et al. | Feb 2003 | B2 |
6514534 | Sawhney | Feb 2003 | B1 |
6517566 | Hovland et al. | Feb 2003 | B1 |
6551356 | Rousseau | Apr 2003 | B2 |
6566406 | Pathak et al. | May 2003 | B1 |
6590095 | Schleicher et al. | Jul 2003 | B1 |
6592597 | Grant et al. | Jul 2003 | B2 |
6605294 | Sawhney | Aug 2003 | B2 |
6627749 | Kumar | Sep 2003 | B1 |
6638285 | Gabbay | Oct 2003 | B2 |
6652594 | Francis et al. | Nov 2003 | B2 |
6656193 | Grant et al. | Dec 2003 | B2 |
6656200 | Li et al. | Dec 2003 | B2 |
6669735 | Pelissier | Dec 2003 | B1 |
6673093 | Sawhney | Jan 2004 | B1 |
6677258 | Carroll et al. | Jan 2004 | B2 |
6685714 | Rousseau | Feb 2004 | B2 |
6702828 | Whayne | Mar 2004 | B2 |
6703047 | Sawhney et al. | Mar 2004 | B2 |
6704210 | Myers | Mar 2004 | B1 |
6723114 | Shalaby | Apr 2004 | B2 |
6726706 | Dominguez | Apr 2004 | B2 |
6736823 | Darois et al. | May 2004 | B2 |
6736854 | Vadurro et al. | May 2004 | B2 |
6746458 | Cloud | Jun 2004 | B1 |
6746869 | Pui et al. | Jun 2004 | B2 |
6764720 | Pui et al. | Jul 2004 | B2 |
6773458 | Brauker et al. | Aug 2004 | B1 |
6818018 | Sawhney | Nov 2004 | B1 |
6896684 | Monassevitch et al. | May 2005 | B2 |
6927315 | Heinecke et al. | Aug 2005 | B1 |
6939358 | Palacios et al. | Sep 2005 | B2 |
6946196 | Foss | Sep 2005 | B2 |
6959851 | Heinrich | Nov 2005 | B2 |
7009034 | Pathak et al. | Mar 2006 | B2 |
7060087 | DiMatteo et al. | Jun 2006 | B2 |
7087065 | Ulmsten et al. | Aug 2006 | B2 |
7108701 | Evens et al. | Sep 2006 | B2 |
7128253 | Mastri et al. | Oct 2006 | B2 |
7128748 | Mooradian et al. | Oct 2006 | B2 |
7141055 | Abrams et al. | Nov 2006 | B2 |
7147138 | Shelton, IV | Dec 2006 | B2 |
7160299 | Baily | Jan 2007 | B2 |
7232449 | Sharkawy et al. | Jun 2007 | B2 |
7241300 | Sharkawy et al. | Jul 2007 | B2 |
7247338 | Pui et al. | Jul 2007 | B2 |
7279322 | Pui et al. | Oct 2007 | B2 |
7294357 | Roby | Nov 2007 | B2 |
7307031 | Carroll et al. | Dec 2007 | B2 |
7311720 | Mueller et al. | Dec 2007 | B2 |
7347850 | Sawhney | Mar 2008 | B2 |
7377928 | Zubik et al. | May 2008 | B2 |
7434717 | Shelton, IV et al. | Oct 2008 | B2 |
7438209 | Hess et al. | Oct 2008 | B1 |
7498063 | Pui et al. | Mar 2009 | B2 |
7547312 | Bauman et al. | Jun 2009 | B2 |
7559937 | de la Torre et al. | Jul 2009 | B2 |
7594921 | Browning | Sep 2009 | B2 |
7595392 | Kumar et al. | Sep 2009 | B2 |
7604151 | Hess et al. | Oct 2009 | B2 |
7611494 | Campbell et al. | Nov 2009 | B2 |
7649089 | Kumar et al. | Jan 2010 | B2 |
7662801 | Kumar et al. | Feb 2010 | B2 |
7665646 | Prommersberger | Feb 2010 | B2 |
7666198 | Suyker et al. | Feb 2010 | B2 |
7669747 | Weisenburgh, II et al. | Mar 2010 | B2 |
7717313 | Criscuolo et al. | May 2010 | B2 |
7722642 | Williamson, IV et al. | May 2010 | B2 |
7744627 | Orban, III et al. | Jun 2010 | B2 |
7776060 | Mooradian et al. | Aug 2010 | B2 |
7793813 | Bettuchi | Sep 2010 | B2 |
7799026 | Schechter et al. | Sep 2010 | B2 |
7823592 | Bettuchi et al. | Nov 2010 | B2 |
7824420 | Eldridge et al. | Nov 2010 | B2 |
7845533 | Marczyk et al. | Dec 2010 | B2 |
7845536 | Viola et al. | Dec 2010 | B2 |
7846149 | Jankowski | Dec 2010 | B2 |
7892247 | Conston et al. | Feb 2011 | B2 |
7909224 | Prommersberger | Mar 2011 | B2 |
7909837 | Crews et al. | Mar 2011 | B2 |
7938307 | Bettuchi | May 2011 | B2 |
7942890 | D'Agostino et al. | May 2011 | B2 |
7950561 | Aranyi | May 2011 | B2 |
7951166 | Orban, III et al. | May 2011 | B2 |
7951248 | Fallis et al. | May 2011 | B1 |
7967179 | Olson et al. | Jun 2011 | B2 |
7988027 | Olson et al. | Aug 2011 | B2 |
7989371 | Angadjivand et al. | Aug 2011 | B2 |
8011550 | Aranyi et al. | Sep 2011 | B2 |
8011555 | Tarinelli et al. | Sep 2011 | B2 |
8016177 | Bettuchi et al. | Sep 2011 | B2 |
8016178 | Olson et al. | Sep 2011 | B2 |
8028883 | Stopek | Oct 2011 | B2 |
8033483 | Fortier et al. | Oct 2011 | B2 |
8038045 | Bettuchi et al. | Oct 2011 | B2 |
8062330 | Prommersberger et al. | Nov 2011 | B2 |
8083119 | Prommersberger | Dec 2011 | B2 |
8123766 | Bauman et al. | Feb 2012 | B2 |
8123767 | Bauman et al. | Feb 2012 | B2 |
8146791 | Bettuchi et al. | Apr 2012 | B2 |
8152777 | Campbell et al. | Apr 2012 | B2 |
8157149 | Olson et al. | Apr 2012 | B2 |
8157151 | Ingmanson et al. | Apr 2012 | B2 |
8167895 | D'Agostino et al. | May 2012 | B2 |
8192460 | Orban, III et al. | Jun 2012 | B2 |
8210414 | Bettuchi et al. | Jul 2012 | B2 |
8225799 | Bettuchi | Jul 2012 | B2 |
8225981 | Criscuolo et al. | Jul 2012 | B2 |
8231043 | Tarinelli et al. | Jul 2012 | B2 |
8235273 | Olson et al. | Aug 2012 | B2 |
8245901 | Stopek | Aug 2012 | B2 |
8256654 | Bettuchi et al. | Sep 2012 | B2 |
8257391 | Orban, III et al. | Sep 2012 | B2 |
8276800 | Bettuchi | Oct 2012 | B2 |
8286849 | Bettuchi | Oct 2012 | B2 |
8308042 | Aranyi | Nov 2012 | B2 |
8308045 | Bettuchi et al. | Nov 2012 | B2 |
8308046 | Prommersberger | Nov 2012 | B2 |
8312885 | Bettuchi et al. | Nov 2012 | B2 |
8313014 | Bettuchi | Nov 2012 | B2 |
8348126 | Olson et al. | Jan 2013 | B2 |
8348130 | Shah et al. | Jan 2013 | B2 |
8365972 | Aranyi et al. | Feb 2013 | B2 |
8371491 | Huitema et al. | Feb 2013 | B2 |
8371492 | Aranyi et al. | Feb 2013 | B2 |
8371493 | Aranyi et al. | Feb 2013 | B2 |
8393514 | Shelton, IV et al. | Mar 2013 | B2 |
8408440 | Olson et al. | Apr 2013 | B2 |
8413871 | Racenet et al. | Apr 2013 | B2 |
8424742 | Bettuchi | Apr 2013 | B2 |
8453652 | Stopek | Jun 2013 | B2 |
8453904 | Eskaros et al. | Jun 2013 | B2 |
8453909 | Olson et al. | Jun 2013 | B2 |
8453910 | Bettuchi et al. | Jun 2013 | B2 |
8464925 | Hull et al. | Jun 2013 | B2 |
8474677 | Woodard, Jr. et al. | Jul 2013 | B2 |
8479968 | Hodgkinson et al. | Jul 2013 | B2 |
8485414 | Criscuolo et al. | Jul 2013 | B2 |
8496683 | Prommersberger et al. | Jul 2013 | B2 |
8511533 | Viola et al. | Aug 2013 | B2 |
8512402 | Marczyk et al. | Aug 2013 | B2 |
8529600 | Woodard, Jr. et al. | Sep 2013 | B2 |
8540131 | Swayze | Sep 2013 | B2 |
8551138 | Orban, III et al. | Oct 2013 | B2 |
8556918 | Bauman et al. | Oct 2013 | B2 |
8561873 | Ingmanson et al. | Oct 2013 | B2 |
8584920 | Hodgkinson | Nov 2013 | B2 |
8590762 | Hess et al. | Nov 2013 | B2 |
8616430 | (Prommersberger) Stopek et al. | Dec 2013 | B2 |
8631989 | Aranyi et al. | Jan 2014 | B2 |
8668129 | Olson | Mar 2014 | B2 |
8684250 | Bettuchi et al. | Apr 2014 | B2 |
8757466 | Olson et al. | Jun 2014 | B2 |
8789737 | Hodgkinson et al. | Jul 2014 | B2 |
8820606 | Hodgkinson | Sep 2014 | B2 |
9266046 | Kuroda et al. | Feb 2016 | B2 |
20010000189 | Hayes | Apr 2001 | A1 |
20020028243 | Masters | Mar 2002 | A1 |
20020086990 | Kumar et al. | Jul 2002 | A1 |
20020091397 | Chen | Jul 2002 | A1 |
20030065345 | Weadock | Apr 2003 | A1 |
20030078209 | Schmidt | Apr 2003 | A1 |
20030083676 | Wallace | May 2003 | A1 |
20030120284 | Palacios et al. | Jun 2003 | A1 |
20030181927 | Wallace | Sep 2003 | A1 |
20030183671 | Mooradian et al. | Oct 2003 | A1 |
20030208231 | Williamson et al. | Nov 2003 | A1 |
20040107006 | Francis et al. | Jun 2004 | A1 |
20040254590 | Hoffman et al. | Dec 2004 | A1 |
20040260315 | Dell et al. | Dec 2004 | A1 |
20050002981 | Lahtinen et al. | Jan 2005 | A1 |
20050021085 | Abrams et al. | Jan 2005 | A1 |
20050059996 | Bauman et al. | Mar 2005 | A1 |
20050059997 | Bauman et al. | Mar 2005 | A1 |
20050070929 | Dalessandro et al. | Mar 2005 | A1 |
20050118435 | DeLucia et al. | Jun 2005 | A1 |
20050131225 | Kumar et al. | Jun 2005 | A1 |
20050149073 | Arani et al. | Jul 2005 | A1 |
20050154093 | Kwon et al. | Jul 2005 | A1 |
20060004407 | Hiles et al. | Jan 2006 | A1 |
20060008505 | Brandon | Jan 2006 | A1 |
20060093672 | Kumar et al. | May 2006 | A1 |
20060121266 | Fandel et al. | Jun 2006 | A1 |
20060135992 | Bettuchi et al. | Jun 2006 | A1 |
20060173470 | Oray et al. | Aug 2006 | A1 |
20060178683 | Shimoji et al. | Aug 2006 | A1 |
20060271104 | Viola et al. | Nov 2006 | A1 |
20070026031 | Bauman et al. | Feb 2007 | A1 |
20070034669 | de la Torre et al. | Feb 2007 | A1 |
20070049953 | Shimoji et al. | Mar 2007 | A2 |
20070054880 | Saferstein et al. | Mar 2007 | A1 |
20070057414 | Hartge | Mar 2007 | A1 |
20070123839 | Rousseau et al. | May 2007 | A1 |
20070179528 | Soltz et al. | Aug 2007 | A1 |
20070203509 | Bettuchi | Aug 2007 | A1 |
20070203510 | Bettuchi | Aug 2007 | A1 |
20070213522 | Harris et al. | Sep 2007 | A1 |
20070237741 | Figuly et al. | Oct 2007 | A1 |
20070237742 | Figuly et al. | Oct 2007 | A1 |
20070246505 | Pace-Floridia et al. | Oct 2007 | A1 |
20080026659 | Brandner et al. | Jan 2008 | A1 |
20080029570 | Shelton et al. | Feb 2008 | A1 |
20080082126 | Murray et al. | Apr 2008 | A1 |
20080110959 | Orban et al. | May 2008 | A1 |
20080125812 | Zubik et al. | May 2008 | A1 |
20080140115 | Stopek | Jun 2008 | A1 |
20080161831 | Bauman et al. | Jul 2008 | A1 |
20080161832 | Bauman et al. | Jul 2008 | A1 |
20080164440 | Maase et al. | Jul 2008 | A1 |
20080169327 | Shelton et al. | Jul 2008 | A1 |
20080169328 | Shelton | Jul 2008 | A1 |
20080169329 | Shelton et al. | Jul 2008 | A1 |
20080169330 | Shelton et al. | Jul 2008 | A1 |
20080169331 | Shelton et al. | Jul 2008 | A1 |
20080169332 | Shelton et al. | Jul 2008 | A1 |
20080169333 | Shelton et al. | Jul 2008 | A1 |
20080194805 | Vignon et al. | Aug 2008 | A1 |
20080200949 | Hiles et al. | Aug 2008 | A1 |
20080214695 | Pathak et al. | Sep 2008 | A1 |
20080290134 | Bettuchi et al. | Nov 2008 | A1 |
20080308608 | Prommersberger | Dec 2008 | A1 |
20080314960 | Marczyk et al. | Dec 2008 | A1 |
20090001121 | Hess et al. | Jan 2009 | A1 |
20090001122 | Prommersberger et al. | Jan 2009 | A1 |
20090001123 | Morgan et al. | Jan 2009 | A1 |
20090001124 | Hess et al. | Jan 2009 | A1 |
20090001125 | Hess et al. | Jan 2009 | A1 |
20090001126 | Hess et al. | Jan 2009 | A1 |
20090001128 | Weisenburgh, II et al. | Jan 2009 | A1 |
20090001130 | Hess et al. | Jan 2009 | A1 |
20090005808 | Hess et al. | Jan 2009 | A1 |
20090030452 | Bauman et al. | Jan 2009 | A1 |
20090043334 | Bauman et al. | Feb 2009 | A1 |
20090076510 | Bell et al. | Mar 2009 | A1 |
20090076528 | Sgro | Mar 2009 | A1 |
20090078739 | Viola | Mar 2009 | A1 |
20090095791 | Eskaros et al. | Apr 2009 | A1 |
20090095792 | Bettuchi | Apr 2009 | A1 |
20090120994 | Murray et al. | May 2009 | A1 |
20090134200 | Tarinelli et al. | May 2009 | A1 |
20090206125 | Huitema et al. | Aug 2009 | A1 |
20090206126 | Huitema et al. | Aug 2009 | A1 |
20090206139 | Hall et al. | Aug 2009 | A1 |
20090206141 | Huitema et al. | Aug 2009 | A1 |
20090206142 | Huitema et al. | Aug 2009 | A1 |
20090206143 | Huitema et al. | Aug 2009 | A1 |
20090218384 | Aranyi | Sep 2009 | A1 |
20090220560 | Wan et al. | Sep 2009 | A1 |
20090263441 | McKay | Oct 2009 | A1 |
20090277947 | Viola | Nov 2009 | A1 |
20090287230 | D'Agostino et al. | Nov 2009 | A1 |
20100012704 | Tarinelli Racenet et al. | Jan 2010 | A1 |
20100065606 | Stopek | Mar 2010 | A1 |
20100065607 | Orban, III et al. | Mar 2010 | A1 |
20100065660 | Hull et al. | Mar 2010 | A1 |
20100072254 | Aranyi et al. | Mar 2010 | A1 |
20100096481 | Hull et al. | Apr 2010 | A1 |
20100147921 | Olson | Jun 2010 | A1 |
20100147922 | Olson | Jun 2010 | A1 |
20100147923 | D'Agostino et al. | Jun 2010 | A1 |
20100203151 | Hiraoka | Aug 2010 | A1 |
20100243707 | Olson et al. | Sep 2010 | A1 |
20100243708 | Aranyi et al. | Sep 2010 | A1 |
20100243711 | Olson et al. | Sep 2010 | A1 |
20100249805 | Olson et al. | Sep 2010 | A1 |
20100264195 | Bettuchi | Oct 2010 | A1 |
20100282815 | Bettuchi et al. | Nov 2010 | A1 |
20110024476 | Bettuchi et al. | Feb 2011 | A1 |
20110024481 | Bettuchi et al. | Feb 2011 | A1 |
20110036894 | Bettuchi | Feb 2011 | A1 |
20110042442 | Viola et al. | Feb 2011 | A1 |
20110046650 | Bettuchi | Feb 2011 | A1 |
20110057016 | Bettuchi | Mar 2011 | A1 |
20110082427 | Golzarian et al. | Apr 2011 | A1 |
20110087279 | Shah et al. | Apr 2011 | A1 |
20110089375 | Chan et al. | Apr 2011 | A1 |
20110215132 | Aranyi et al. | Sep 2011 | A1 |
20110293690 | Griffin et al. | Dec 2011 | A1 |
20120074199 | Olson et al. | Mar 2012 | A1 |
20120080336 | Shelton, IV et al. | Apr 2012 | A1 |
20120156289 | Blaskovich et al. | Jun 2012 | A1 |
20120187179 | Gleiman | Jul 2012 | A1 |
20120241499 | Baxter, III et al. | Sep 2012 | A1 |
20120273547 | Hodgkinson et al. | Nov 2012 | A1 |
20120315225 | Porbeni et al. | Dec 2012 | A1 |
20130037596 | Bear et al. | Feb 2013 | A1 |
20130105548 | Hodgkinson et al. | May 2013 | A1 |
20130105553 | (Tarinelli) Racenet et al. | May 2013 | A1 |
20130112732 | Aranyi et al. | May 2013 | A1 |
20130112733 | Aranyi et al. | May 2013 | A1 |
20130123816 | Hodgkinson et al. | May 2013 | A1 |
20130146641 | Shelton, IV et al. | Jun 2013 | A1 |
20130153633 | Casasanta, Jr. et al. | Jun 2013 | A1 |
20130153634 | Carter et al. | Jun 2013 | A1 |
20130153635 | Hodgkinson | Jun 2013 | A1 |
20130153636 | Shelton, IV et al. | Jun 2013 | A1 |
20130153638 | Carter et al. | Jun 2013 | A1 |
20130153639 | Hodgkinson et al. | Jun 2013 | A1 |
20130153640 | Hodgkinson | Jun 2013 | A1 |
20130153641 | Shelton, IV et al. | Jun 2013 | A1 |
20130161374 | Swayze et al. | Jun 2013 | A1 |
20130181031 | Olson et al. | Jul 2013 | A1 |
20130193186 | (Tarinelli) Racenet et al. | Aug 2013 | A1 |
20130193190 | Carter et al. | Aug 2013 | A1 |
20130193191 | Stevenson et al. | Aug 2013 | A1 |
20130193192 | Casasanta, Jr. et al. | Aug 2013 | A1 |
20130209659 | Racenet et al. | Aug 2013 | A1 |
20130221062 | Hodgkinson | Aug 2013 | A1 |
20130240600 | Bettuchi | Sep 2013 | A1 |
20130240601 | Bettuchi et al. | Sep 2013 | A1 |
20130240602 | Stopek | Sep 2013 | A1 |
20130277411 | Hodgkinson et al. | Oct 2013 | A1 |
20130306707 | Viola et al. | Nov 2013 | A1 |
20130310873 | Stopek (nee Prommersberger) et al. | Nov 2013 | A1 |
20130327807 | Olson et al. | Dec 2013 | A1 |
20140012317 | Orban et al. | Jan 2014 | A1 |
20140021242 | Hodgkinson et al. | Jan 2014 | A1 |
20140027490 | Marczyk et al. | Jan 2014 | A1 |
20140034704 | Ingmanson et al. | Feb 2014 | A1 |
20140048580 | Merchant et al. | Feb 2014 | A1 |
20140061280 | Ingmanson et al. | Mar 2014 | A1 |
20140061281 | Hodgkinson | Mar 2014 | A1 |
20140084042 | (Prommersberger) Stopek et al. | Mar 2014 | A1 |
20140097224 | Prior | Apr 2014 | A1 |
20140103556 | Diaz de Leon Izquierdo et al. | Apr 2014 | A1 |
20140117066 | Aranyi et al. | May 2014 | A1 |
20140130330 | Olson et al. | May 2014 | A1 |
20140131418 | Kostrzewski | May 2014 | A1 |
20140131419 | Bettuchi | May 2014 | A1 |
20140138423 | Whitfield et al. | May 2014 | A1 |
20140151431 | Hodgkinson et al. | Jun 2014 | A1 |
20140155916 | Hodgkinson et al. | Jun 2014 | A1 |
20140158742 | Stopek (nee Prommersberger) et al. | Jun 2014 | A1 |
20140166721 | Stevenson et al. | Jun 2014 | A1 |
20140197224 | Penna | Jul 2014 | A1 |
20140203061 | Hodgkinson | Jul 2014 | A1 |
20140217147 | Milliman | Aug 2014 | A1 |
20140217148 | Penna | Aug 2014 | A1 |
20140239046 | Milliman | Aug 2014 | A1 |
20140239047 | Hodgkinson et al. | Aug 2014 | A1 |
20140305090 | Kuroda et al. | Oct 2014 | A1 |
Number | Date | Country |
---|---|---|
2 667 434 | May 2008 | CA |
19924311 | Nov 2000 | DE |
0 327 022 | Aug 1989 | EP |
0 594 148 | Apr 1994 | EP |
0 667 119 | Aug 1995 | EP |
1 064 883 | Jan 2001 | EP |
1 256 317 | Nov 2002 | EP |
1 256 318 | Nov 2002 | EP |
1 520 525 | Apr 2005 | EP |
1 621 141 | Feb 2006 | EP |
1 702 570 | Sep 2006 | EP |
1 759 640 | Mar 2007 | EP |
1 815 804 | Aug 2007 | EP |
1 825 820 | Aug 2007 | EP |
1 929 958 | Jun 2008 | EP |
1 994 890 | Nov 2008 | EP |
2 005 894 | Dec 2008 | EP |
2 005 895 | Dec 2008 | EP |
2 008 595 | Dec 2008 | EP |
2 090 231 | Aug 2009 | EP |
2 090 244 | Aug 2009 | EP |
2 090 252 | Aug 2009 | EP |
2 198 787 | Jun 2010 | EP |
2 236 098 | Oct 2010 | EP |
2 236 099 | Oct 2010 | EP |
2 311 386 | Apr 2011 | EP |
2 436 348 | Apr 2012 | EP |
2 462 880 | Jun 2012 | EP |
2 517 637 | Oct 2012 | EP |
2 586 380 | May 2013 | EP |
2 604 195 | Jun 2013 | EP |
2 604 197 | Jun 2013 | EP |
2 620 106 | Jul 2013 | EP |
2 630 922 | Aug 2013 | EP |
2 644 125 | Oct 2013 | EP |
2 792 777 | Oct 2014 | EP |
02289107 | Nov 1990 | JP |
05186240 | Jul 1993 | JP |
08209432 | Aug 1996 | JP |
11131353 | May 1999 | JP |
2000-166933 | Jun 2000 | JP |
2001040566 | Feb 2001 | JP |
2002-202213 | Jul 2002 | JP |
2007-124166 | May 2007 | JP |
9005489 | May 1990 | WO |
9516221 | Jun 1995 | WO |
9622055 | Jul 1996 | WO |
9701989 | Jan 1997 | WO |
9713463 | Apr 1997 | WO |
9817180 | Apr 1998 | WO |
9923285 | May 1999 | WO |
9945849 | Sep 1999 | WO |
03088845 | Oct 2003 | WO |
03082126 | Oct 2003 | WO |
03094743 | Nov 2003 | WO |
03105698 | Dec 2003 | WO |
2005079675 | Sep 2005 | WO |
2006023578 | Mar 2006 | WO |
2006044490 | Apr 2006 | WO |
2006083748 | Aug 2006 | WO |
2007121579 | Nov 2007 | WO |
2008057281 | May 2008 | WO |
2008109125 | Sep 2008 | WO |
2008085546 | Dec 2008 | WO |
2010075298 | Jul 2010 | WO |
2011143183 | Nov 2011 | WO |
2012044848 | Apr 2012 | WO |
Entry |
---|
Extended European Search Report corresponding to EP 13 19 4995.0, completed Jun. 5, 2014 and dated Jun. 16, 2014; (5 pp). |
Extended European Search Report corresponding to EP 14 15 7195.0, completed Jun. 5, 2014 and dated Jun. 18, 2014; (9 pp). |
Extended European Search Report corresponding to EP 14 15 6342.9, completed Jul. 22, 2014 and dated Jul. 29, 2014; (8 pp). |
Extended European Search Report corresponding to counterpart Int'l Appln. No. EP 15 20 0068.3 dated Jun. 3, 2016. |
European Search Report corresponding to EP 05 02 2585.3, completed Jan. 25, 2006 and dated Feb. 3, 2006; (4 pp). |
European Search Report corresponding to EP 06 00 4598, completed Jun. 22, 2006; (2 pp). |
European Search Report corresponding to EP 06 01 6962.0, completed Jan. 3, 2007 and dated Jan. 11, 2007; (10 pp). |
International Search Report corresponding to International Application No. PCT/US2005/036740, completed Feb. 20, 2007 and dated Mar. 23, 2007; (8 pp). |
International Search Report corresponding to International Application No. PCT/US2007/022713, completed Apr. 21, 2008 and dated May 15, 2008; (1 p). |
International Search Report corresponding to International Application No. PCT/US2008/002981, completed Jun. 9, 2008 and dated Jun. 26, 2008; (2 pp). |
European Search Report corresponding to EP 08 25 1779, completed Jul. 14, 2008 and dated Jul. 23, 2008; (5 pp). |
European Search Report corresponding to EP 08 25 1989.3, completed Mar. 11, 2010 and dated Mar. 24, 2010; (6 pp). |
European Search Report corresponding to EP 10 25 0639.1, completed Jun. 17, 2010 and dated Jun. 28, 2010; (7 pp). |
European Search Report corresponding to EP 10 25 0715.9, completed Jun. 30, 2010 and dated Jul. 20, 2010; (3 pp). |
European Search Report corresponding to EP 05 80 4382.9, completed Oct. 5, 2010 and dated Oct. 12, 2010; (3 pp). |
European Search Report corresponding to EP 10 25 1437.9, completed Nov. 22, 2010 and dated Dec. 16, 2010; (3 pp). |
European Search Report corresponding to EP 09 25 2897.5, completed Feb. 7, 2011 and dated Feb. 15, 2011; (3 pp). |
European Search Report corresponding to EP 10 25 0642.5, completed Mar. 25, 2011 and dated Apr. 4, 2011; (4 pp). |
European Search Report corresponding to EP 11 18 8309.6, completed Dec. 15, 2011 and dated Jan. 12, 2012; (3 pp). |
European Search Report corresponding to EP 12 15 2229.6, completed Feb. 23, 2012 and dated Mar. 1, 2012; (4 pp). |
European Search Report corresponding to EP 12 15 0511.9, completed Apr. 16, 2012 and dated Apr. 24, 2012; (7 pp). |
European Search Report corresponding to EP 12 15 2541.4, completed Apr. 23, 2012 and dated May 3, 2012; (10 pp). |
European Search Report corresponding to EP 12 16 5609.4, completed Jul. 5, 2012 and dated Jul. 13, 2012; (8 pp). |
European Search Report corresponding to EP 12 15 8861.0, completed Jul. 17, 2012 and dated Jul. 24, 2012; (9 pp). |
European Search Report corresponding to EP 12 16 5878.5, completed Jul. 24, 2012 and dated Aug. 6, 2012; (8 pp). |
Extended European Search Report corresponding to EP 12 19 1035.0, completed Jan. 11, 2013 and dated Jan. 18, 2013; (7 pp). |
Extended European Search Report corresponding to EP 12 18 6175.1, completed Jan. 15, 2013 and dated Jan. 23, 2013; (7 pp). |
Extended European Search Report corresponding to EP 12 19 1114.3, completed Jan. 23, 2013 and dated Jan. 31, 2013; (10 pp). |
Extended European Search Report corresponding to EP 12 19 2224.9, completed Mar. 14, 2013 and dated Mar. 26, 2013; (8 pp). |
Extended European Search Report corresponding to EP 12 19 6904.2, completed Mar. 28, 2013 and dated Jul. 26, 2013; (8 pp). |
Extended European Search Report corresponding to EP 12 19 6911.7, completed Apr. 18, 2013 and dated Apr. 24, 2013; (8 pp). |
Extended European Search Report corresponding to EP 07 00 5842.5, completed May 13, 2013 and dated May 29, 2013; (7 pp). |
Extended European Search Report corresponding to EP 12 19 8776.2, completed May 16, 2013 and dated May 27, 2013; (8 pp). |
Extended European Search Report corresponding to EP 12 19 8749.9, completed May 21, 2013 and dated May 31, 2013; (8 pp). |
Extended European Search Report corresponding to EP 13 15 6297.7, completed Jun. 4, 2013 and dated Jun. 13, 2013I; (7 pp). |
Extended European Search Report corresponding to EP 13 17 3985.6, completed Aug. 19, 2013 and dated Aug. 28, 2013; (6 pp). |
Extended European Search Report corresponding to EP 13 17 3986.4, completed Aug. 20, 2013 and dated Aug. 29, 2013; (6 pp). |
Extended European Search Report corresponding to EP 13 17 7437.4, completed Sep. 11, 2013 and dated Sep. 19, 2013; 6 pages. |
Extended European Search Report corresponding to EP 13 17 7441.6, completed Sep. 11, 2013 and dated Sep. 19, 2013; (6 pp). |
Extended European Search Report corresponding to EP 07 86 1534.1, completed Sep. 20, 2013 and dated Sep. 30, 2013; (5 pp). |
Extended European Search Report corresponding to EP 13 18 3876.5, completed Oct. 14, 2013 and dated Oct. 24, 2013; (5 pp). |
Extended European Search Report corresponding to EP 13 17 1856.1, completed Oct. 29, 2013 and dated Nov. 7, 2013; (8 pp). |
Extended European Search Report corresponding to EP 13 18 0373.6, completed Oct. 31, 2013 and dated Nov. 13, 2013; (7 pp). |
Extended European Search Report corresponding to EP 13 18 0881.8, completed Nov. 5, 2013 and dated Nov. 14, 2013; (6 pp). |
Extended European Search Report corresponding to EP 13 17 6895.4, completed Nov. 29, 2013 and dated Dec. 12, 2013; (5 pp). |
Extended European Search Report corresponding to EP 13 18 2911.1, completed Dec. 2, 2013 and dated Dec. 16, 2013; (8 pp). |
Extended European Search Report corresponding to EP 10 25 1795.0, completed Dec. 11, 2013 and dated Dec. 20, 2013; (6 pp). |
Extended European Search Report corresponding to EP 13 18 7911.6, completed Jan. 22, 2014 and dated Jan. 31, 2014; (8 pp). |
Extended European Search Report corresponding to EP 13 19 2111.6, completed Feb. 13, 2014 and dated Feb. 27, 2014; (10 pp). |
Extended European Search Report corresponding to EP 13 19 5919.9, completed Feb. 10, 2014 and dated Mar. 3, 2014; (7 pp). |
Extended European Search Report corresponding to EP 08 72 6500.5, completed Feb. 20, 2014 and dated Mar. 3, 2014; (7 pp). |
Extended European Search Report corresponding to EP 13 19 5019.8, completed Mar. 14, 2014 and dated Mar. 24, 2014; (7 pp). |
Extended European Search Report corresponding to EP 13 19 6816.6, completed Mar. 28, 2014 and dated Apr. 9, 2014; (9 pp). |
Extended European Search Report corresponding to EP 13 19 7958.5, completed Apr. 4, 2014 and dated Apr. 15, 2014; (8 pp). |
European Office Action corresponding to counterpart Int'l Application No. EP 15 20 0068.3 dated Sep. 8, 2017. |
Chinese First Office Action corresponding to counterpart Patent Appln. CN 201510896261.0 dated Dec. 26, 2018. |
Chinese Third Office Action dated Jul. 2, 2019 corresponding to counterpart Patent Application CN 201510896261.0. |
Chinese Second Office Action corresponding to counterpart Patent Appln. CN 201510896261.0 dated Apr. 23, 2019. |
Japanese Office Action dated Dec. 2, 2019 corresponding to counterpart Patent Application JP 2015-239080. |
Australian Examination Report No. 1 dated Jun. 5, 2020 corresponding to counterpart Patent Application AU 2015252118. |
Number | Date | Country | |
---|---|---|---|
20160183929 A1 | Jun 2016 | US |